|
ADAP
|
Adaptimmune Therapeutics plc
|
US
|
NASDAQ
|
|
FENC
|
Fennec Pharmaceuticals Inc.
|
US
|
NASDAQ
|
|
IMMX
|
Immix Biopharma, Inc.
|
US
|
NASDAQ
|
|
INBX
|
Inhibrx, Inc.
|
US
|
NASDAQ
|
|
KNTE
|
Kinnate Biopharma Inc.
|
US
|
NASDAQ
|
|
LGND
|
Ligand Pharmaceuticals Incorporated
|
US
|
NASDAQ
|
|
LIXT
|
Lixte Biotechnology Holdings, Inc.
|
US
|
NASDAQ
|
|
MNPR
|
Monopar Therapeutics Inc.
|
US
|
NASDAQ
|
|
ONCT
|
Oncternal Therapeutics, Inc.
|
US
|
NASDAQ
|
|
PIRS
|
Pieris Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
PSTV
|
Plus Therapeutics, Inc.
|
US
|
NASDAQ
|
|
SHPH
|
Shuttle Pharmaceuticals Holdings, Inc.
|
US
|
NASDAQ
|
|
SLRX
|
Salarius Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
SPPI
|
Spectrum Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
TCON
|
TRACON Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
VCNX
|
Vaccinex, Inc.
|
US
|
NASDAQ
|
|
HMDCF
|
Hutchison China Ltd
|
US
|
OTC
|
|
PHMMF
|
Pharma Mar S.A.U.
|
US
|
OTC
|
|
RASP
|
Rasna Therapeutics Inc
|
US
|
OTC
|
|
0013
|
HUTCHMED China Ltd
|
HK
|
HK
|